RXST
HealthcareRxSight, Inc.
$10.46
+$0.08 (+0.77%)
Jan 5, 2026
Price History (1Y)
Analysis
RxSight, Inc. is a healthcare company operating within the medical devices industry. With a market capitalization of $430.08M and revenue of $142.08M (TTM), the company has a substantial presence in its sector. Its workforce comprises 498 employees. The financial health of RxSight, Inc. indicates significant challenges. The company's profitability is weak, with gross margins at 75.0%, operating margin at -40.1%, and profit margin at -25.1%. Returns on equity (ROE) and assets (ROA) are also negative, standing at -12.9% and -9.2%, respectively. The balance sheet shows a relatively low debt level of $11.56M but a substantial cash position of $227.52M. Valuation metrics for RxSight, Inc. include a forward P/E ratio of -21.19 and an EV/EBITDA of -4.96. Revenue growth has been declining at a rate of -14.1% (YoY). The company does not offer a dividend yield, as indicated by the N/A entry in this category.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About RxSight, Inc.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Visit website →Key Statistics
- Market Cap
- $430.08M
- P/E Ratio
- N/A
- 52-Week High
- $37.13
- 52-Week Low
- $6.32
- Avg Volume
- 757.64K
- Beta
- 1.14
Company Info
- Industry
- Medical Devices
- Exchange
- NGM
- Country
- United States
- Employees
- 498